Cargando…

SLE and Serum Complement: Causative, Concomitant or Coincidental?

BACKGROUND: Systemic Lupus Erythematosus (SLE) is an incurable autoimmune disorder with complement activation playing a key role in the pathogenesis of immune-mediated tissue injury. While quantifying complement to monitor SLE disease activity has been the standard of care since the 1950s, decreased...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandhu, Vaneet, Quan, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737025/
https://www.ncbi.nlm.nih.gov/pubmed/29290848
http://dx.doi.org/10.2174/1874312901711010113
_version_ 1783287463239745536
author Sandhu, Vaneet
Quan, Michele
author_facet Sandhu, Vaneet
Quan, Michele
author_sort Sandhu, Vaneet
collection PubMed
description BACKGROUND: Systemic Lupus Erythematosus (SLE) is an incurable autoimmune disorder with complement activation playing a key role in the pathogenesis of immune-mediated tissue injury. While quantifying complement to monitor SLE disease activity has been the standard of care since the 1950s, decreased complement levels are not consistently associated with flares. OBJECTIVE: We seek to clarify the SLE phenotype in which complement deficiency is causative, concomitant, or coincidental. METHODS: A PUBMED literature review was conducted using key words 'complement,' 'SLE,’ and ‘SLE flares’ in English-only journals from 1972-2017. Relevant clinical studies and review articles were found that examined the measurement of complement levels in SLE, and more specifically, interpretation of low serum complement levels regardless of disease activity. CONCLUSION: Complement activation plays a key role in the pathophysiology of SLE and it is recommended to continue monitoring serum levels of C3 and C4 to assess for disease activity. However, it is important to note that decreased serum complement is not consistently associated with disease flares. It is clinically important to find novel ways to assess disease activity in SLE. Increased serum levels of cell-bound complement activation products may more accurately reflect disease activity than conventional serum C3 and C4 monitoring.
format Online
Article
Text
id pubmed-5737025
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-57370252017-12-29 SLE and Serum Complement: Causative, Concomitant or Coincidental? Sandhu, Vaneet Quan, Michele Open Rheumatol J Article BACKGROUND: Systemic Lupus Erythematosus (SLE) is an incurable autoimmune disorder with complement activation playing a key role in the pathogenesis of immune-mediated tissue injury. While quantifying complement to monitor SLE disease activity has been the standard of care since the 1950s, decreased complement levels are not consistently associated with flares. OBJECTIVE: We seek to clarify the SLE phenotype in which complement deficiency is causative, concomitant, or coincidental. METHODS: A PUBMED literature review was conducted using key words 'complement,' 'SLE,’ and ‘SLE flares’ in English-only journals from 1972-2017. Relevant clinical studies and review articles were found that examined the measurement of complement levels in SLE, and more specifically, interpretation of low serum complement levels regardless of disease activity. CONCLUSION: Complement activation plays a key role in the pathophysiology of SLE and it is recommended to continue monitoring serum levels of C3 and C4 to assess for disease activity. However, it is important to note that decreased serum complement is not consistently associated with disease flares. It is clinically important to find novel ways to assess disease activity in SLE. Increased serum levels of cell-bound complement activation products may more accurately reflect disease activity than conventional serum C3 and C4 monitoring. Bentham Open 2017-09-30 /pmc/articles/PMC5737025/ /pubmed/29290848 http://dx.doi.org/10.2174/1874312901711010113 Text en © 2017 Sandhu et al. https://creativecommons.org/licenses/by/4.0/legalcode This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Article
Sandhu, Vaneet
Quan, Michele
SLE and Serum Complement: Causative, Concomitant or Coincidental?
title SLE and Serum Complement: Causative, Concomitant or Coincidental?
title_full SLE and Serum Complement: Causative, Concomitant or Coincidental?
title_fullStr SLE and Serum Complement: Causative, Concomitant or Coincidental?
title_full_unstemmed SLE and Serum Complement: Causative, Concomitant or Coincidental?
title_short SLE and Serum Complement: Causative, Concomitant or Coincidental?
title_sort sle and serum complement: causative, concomitant or coincidental?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737025/
https://www.ncbi.nlm.nih.gov/pubmed/29290848
http://dx.doi.org/10.2174/1874312901711010113
work_keys_str_mv AT sandhuvaneet sleandserumcomplementcausativeconcomitantorcoincidental
AT quanmichele sleandserumcomplementcausativeconcomitantorcoincidental